Cargando…
CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application
Approximately 25 % of clinically important drugs and numerous environmental carcinogens are metabolised by CYP2D6. Variation in the CYP2D6 gene and concomitant use of tamoxifen (TAM) with certain antidepressants may increase recurrence risk in breast cancer patients due to reduced enzyme activity. I...
Autores principales: | van der Merwe, Nicole, Bouwens, Christianne S. H., Pienaar, Rika, van der Merwe, Lize, Yako, Yandiswa Y., Geiger, Dieter H., Kotze, Maritha J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505529/ https://www.ncbi.nlm.nih.gov/pubmed/22638694 http://dx.doi.org/10.1007/s11011-012-9312-z |
Ejemplares similares
-
Fat Mass and Obesity-Associated (FTO) Gene Polymorphisms Are Associated with Physical Activity, Food Intake, Eating Behaviors, Psychological Health, and Modeled Change in Body Mass Index in Overweight/Obese Caucasian Adults
por: Harbron, Janetta, et al.
Publicado: (2014) -
Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study
por: Oosthuizen, Jaco, et al.
Publicado: (2021) -
Clinical Overestimation of HER2 Positivity in Early Estrogen and Progesterone Receptor–Positive Breast Cancer and the Value of Molecular Subtyping Using BluePrint
por: Myburgh, Ettienne J., et al.
Publicado: (2016) -
Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway
por: van der Merwe, Nicole, et al.
Publicado: (2017) -
Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing
por: Torrorey-Sawe, Rispah, et al.
Publicado: (2020)